Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Nine New Additions to TrumpRx
Published 4 months, 4 weeks ago
Description
In today’s Pharmaceutical Executive Daily, President Trump announces nine additional participants in the TrumpRx program, AstraZeneca reaches a $2 billion licensing agreement with Jacobio Pharma for a pan-KRAS inhibitor, and BioMarin enters a definitive $4.8 billion agreement to acquire Amicus Therapeutics.